No. 20-683

Dirk Wilke, Interim State Health Officer of North Dakota, et al. v. Pharmaceutical Care Management Association

Lower Court: Eighth Circuit
Docketed: 2020-11-17
Status: GVR
Type: Paid
Tags: civil-rights eighth-circuit employee-benefits erisa erisa-preemption health-care-law pharmacy-benefit-managers plan-administration preemption state-regulation
Key Terms:
Arbitration ERISA SocialSecurity
Latest Conference: 2021-02-19
Question Presented (AI Summary)

Whether ERISA preempts state laws regulating pharmacy benefit managers

Question Presented (from Petition)

Questions Presented In Rutledge v. Pharmaceutical Care Management Association, No. 18-540 (U.S.), this Court granted a writ of certiorari to decide whether the Employee Retirement Income Security Act of 1974 preempts an Arkansas law that regulates the rates that pharmacy benefit managers (PBMs) reimburse pharmacies for dispensing generic drugs. In that case, the Eighth Circuit had held that Arkansas’s law made a prohibited “reference to” ERISA plans and had a forbidden “connection with” such plans. In this case, Respondent sought to enjoin two North Dakota laws that regulate, among other things, certain fees that PBMs charge pharmacies, which drugs pharmacists are allowed to dispense, and what pharmacists are allowed to say to their patients. These laws apply the same standards regardless of whether PBMs are providing services to an ERISA or non-ERISA plan. In ruling in Respondent’s favor, the Eighth Circuit applied its decision in Rutledge to do two things. First, it held that, under Rutledge’s logic, North Dakota’s laws make an impermissible “reference to” ERISA plans because they apply to PBMs serving plans that “include[]’ ERISA plans. Second, the court held that a finding of preemption under ERISA nullifies a State law “in its entirety’—even as applied to non-ERISA plans. Because of the first holding, the Eighth Circuit elected not to decide whether North Dakota’s laws also had a forbidden “connection with” ERISA plans. And because of the second holding, the Eighth Circuit stated that it did not reach ii Respondent’s separate claims of preemption under Medicare Part D. The questions presented are: 1. Whether, contrary to decisions of this Court and every other court of appeals that has addressed the issue, ERISA preempts a State law simply because it is broad enough to “include[ ]” ERISA plans among those affected by the law. 2. Whether, contrary to the text of ERISA and decisions of this Court and every other court of appeals to consider the issue, ERISA preempts a State law “in its entirety’—even as that law applies to non-ERISA plans.

Docket Entries

2021-03-26
JUDGMENT ISSUED.
2021-02-22
Petition GRANTED. Judgment VACATED and case REMANDED for further consideration in light of <i>Rutledge</i> v. <i>Pharmaceutical Care Management Assn.</i>, 592 U. S. ___ (2020).
2021-01-27
DISTRIBUTED for Conference of 2/19/2021.
2021-01-11
Brief of Respondent filed.
2020-12-18
Supplemental brief of petitioners Dirk Wilke, et al. filed.
2020-11-27
Motion to extend the time to file a response is granted and the time is extended to and including January 15, 2021.
2020-11-25
Motion to extend the time to file a response from December 17, 2020 to January 15, 2021, submitted to The Clerk.
2020-11-13
Petition for a writ of certiorari filed. (Response due December 17, 2020)

Attorneys

Dirk Wilke, et al.
Robert Thomas SmithKatten Muchin Rosenman LLP, Petitioner
Robert Thomas SmithKatten Muchin Rosenman LLP, Petitioner
Pharmaceutical Care Management Association
Michael B. KimberlyMCDERMOTT WILL & EMERY, Respondent
Michael B. KimberlyMCDERMOTT WILL & EMERY, Respondent